Pastorino L, Cusano R, Nasti S, Faravelli F, Forzano F, Barile M, Gliori S, Muggianu M, Ghigliotti G, Lacaita MG, Lo Muzio L, Bianchi-Scarra’ G
Molecular characterization of Italian Nevoid Basal Cell Carcinoma Syndrome patients.
Hum Mutat. accepted

Mantelli M, Pastorino L, Ghiorzo P, Barile M, Bruno W, Gargiulo S, Sormani MP, Gliori S, Vecchio S, Ciotti P, Sertoli MR, Queirolo P, the Italian Melanoma Intergroup, Goldstein AM and Bianchi Scarrà G.
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients.
Melanoma Res 2004 in press

Pastorino L, Cusano R, Bruno W, Lantieri F, Origone P, Barile M, Gliori S, Shepherd GA, Sturm RA, Bianchi-Scarra G.
Novel MC1R variants in Ligurian melanoma patients and controls.
Hum Mutat. 2004 Sep;24(3):274.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15221796

Ghiorzo P, Mantelli M, Gargiulo S, Gramigni C, Pastorino L, Banelli B, Villaggio B, Coccia MC, Sementa AR, Garre C, Bianchi-Scarra G.
Inverse correlation between p16INK4A expression and NF-kappaB activation in melanoma progression.
Hum Pathol. 2004 Aug;35(8):1029-37.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1529797

Ghiorzo P, Villaggio B, Sementa AR, Hansson J, Platz A, Nicolo G, Spina B, Canepa M, Palmer JM, Hayward NK, Bianchi-Scarra G.
Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients.
Hum Pathol. 2004 Jan;35(1):25-33.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1474572

Ghiorzo P, Pastorino L, Bonelli L, Cusano R, Nicora A, Zupo S, Queirolo P, Sertoli M, Pugliese V, Bianchi-Scarra G.
INK4/ARF germline alterations in pancreatic cancer patients.
Ann Oncol. 2004 Jan;15(1):70-8.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1467912

Casula M, Colombino M, Satta MP, Cossu A, Ascierto PA, Bianchi-Scarra G, Castiglia D, Budroni M, Rozzo C, Manca A, Lissia A, Carboni A, Petretto E, Satriano SM, Botti G, Mantelli M, Ghiorzo P, Stratton MR, Tanda F, Palmieri G;Italian Melanoma Intergroup Study.
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study.
J Clin Oncol. 2004 Jan 15;22(2):286-92

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1472203

Bianchi-ScarràG, Testori A and Mihm M.
What is new in melanoma research: genetics and epidemiology of melanoma in 2003? Review of a workshop held in Milan in May 2003.
Melanoma Res. Apr;14(2):77-84. 2004

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1505703

Ghiorzo P and Bianchi Scarrà G.
Genetics of melanoma susceptibility
Forum (Genoa) 2003 13(2):114-26.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14732879

Mantelli M, Barile M, Ciotti P, Ghiorzo P, Lantieri F, Pastorino L, Catricala C, Torre GD, Folco U, Grammatico P, Padovani L, Pasini B, Rovini D, Queirolo P, Rainero ML, Santi PL, Sertoli RM, Goldstein AM, Bianchi-Scarra G; Societa Italiana Dermatologia; Gruppo Italiano Studi Epidemiologici in Dermatologia.
High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families.
Am J Med Genet. 2002 Jan 22;107(3):214-21.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11807902

Bishop DT, Demenais F, Goldstein AM, Bergman W, Bishop JN, Bressac-de Paillerets B, Chompret A, Ghiorzo P, Gruis N, Hansson J, Harland M, Hayward N,Holland EA, Mann GJ, Mantelli M, Nancarrow D, Platz A, Tucker MA; Melanoma Genetics Consortium.
Geographical variation in the penetrance of CDKN2A mutations for melanoma.
J Natl Cancer Inst. 2002,94:894-903.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12072

Auroy S, Avril MF, Chompret A, Pham D, Goldstein AM, Bianchi-Scarra G, Frebourg T, Joly P, Spatz A, Rubino C, Demenais F, Bressac-de Paillerets B; French Hereditary Melanoma Study Group.
Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect.
Genes Chromosomes Cancer. 2001 Nov;32(3):195-202.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11579459

Della Torre G, Pasini B, Frigerio S, Donghi R, Rovini D, Delia D, Peters G, Huot TJ, Bianchi-Scarra G, Lantieri F, Rodolfo M, Parmiani G, Pierotti MA.
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
Br J Cancer. 2001 Sep 14;85(6):836-44.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11556834

Ciotti P, Van Dyke MW, Bianchi-Scarra G, Musso M.
Characterization of a triplex DNA-binding protein encoded by an alternative reading frame of loricrin.
Eur J Biochem. 2001 Jan;268(2):225-34.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11168355

Musso M, Bianchi-Scarra G, Van Dyke MW.
The yeast CDP1 gene encodes a triple-helical DNA-binding protein.
Nucleic Acids Res. 2000 Nov 1;28(21):4090-6.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11058104

Ghiorzo P, Bianchi-Scarra G.
Reply to Fusaro
Int J Cancer. 2000 Sep 1;87(5):756-7.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10925373

Ciotti P, Struewing JP, Mantelli M, Chompret A, Avril MF, Santi PL, Tucker MA, Bianchi-Scarra G, Bressac-de Paillerets B, Goldstein AM.
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families.
Am J Hum Genet. 2000 Aug;67(2):311-9. Epub 2000 Jun 22

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10869234

Leonardi A, Penco S, Gramigni C, Bason C, Ribizzi G, Gazzola P, Mancardi GL, Bianchi-Scarra G, Abbruzzese M, Garre C.
Granulocyte-macrophage colony-stimulating factor activity in cerebrospinal fluid.
Acta Neurol Scand. 1999 Oct;100(4):274-7.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10510690

Ghiorzo P, Ciotti P, Mantelli M, Heouaine A, Queirolo P, Rainero ML, Ferrari C, Santi PL, De Marchi R, Farris A, Ajmar F, Bruzzi P, Bianchi-Scarra G.
Characterization of Ligurian melanoma families and risk of occurrence of other neoplasia.
Int J Cancer. 1999 Nov 12;83(4):441-8.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10508477

Ciotti P, Pesce GP, Cafiero F, Rainero ML, Sementa A, Nicolo G, Mela GS, Bagnasco M, Santi PL, Bianchi-Scarra G.
Intercellular adhesion molecule-1 (ICAM-1) and granulocyte-macrophage colony stimulating factor (GM-CSF) co-expression in cutaneous malignant melanoma lesions.
Melanoma Res. 1999 Jun;9(3):253-60.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10465581